Cell therapy is being tested in the fight against the acquired immunodeficiency syndrome
Journal of the American Osteopathic Association 93(2): 194
1993
ISSN/ISBN: 0098-6151 PMID: 8432667 Document Number: 415333
Document emailed within 1 workday
Related Documents
Tsuchie, H.; Kawatani, T.; Nakayama, E.; Matsui, T.; Kurimura, T.; Hinuma, Y. 1985: Distribution of the level of antibody to acquired immunodeficiency syndrome associated virus in sera from acquired immunodeficiency syndrome related complex and japanese hemophiliacs infected with acquired immunodeficiency syndrome associated virus Microbiology and Immunology 29(11): 1083-1088Crumpacker, C.; Heagy, W.; Bubley, G.; Monroe, J.E.; Finberg, R.; Hussey, S.; Schnipper, L.; Lucey, D.; Lee, T.H.; McLane, M.F. 1987: Ribavirin treatment of the acquired immunodeficiency syndrome (AIDS) and the acquired-immunodeficiency-syndrome-related complex (ARC). A phase 1 study shows transient clinical improvement associated with suppression of the human immunodeficiency virus and enhanced lymphocyte proliferation Annals of Internal Medicine 107(5): 664-674
Borek, E.; Sharma, O.K.; Buschman, F.L.; Cohn, D.L.; Penley, K.A.; Judson, F.N.; Dobozin, B.S.; Horsburgh, C.R.; Kirkpatrick, C.H. 1986: Altered excretion of modified nucleosides and beta-aminoisobutyric acid in subjects with acquired immunodeficiency syndrome or at risk for acquired immunodeficiency syndrome Cancer Research 46(5): 2557-2561
Ambrus, J.L.; Poiesz, B.J.; Lillie, M.A.; Stadler, I.; Di Berardino, L.A.; Chadha, K.C. 1989: Interferon and interferon inhibitor levels in patients infected with varicella-zoster virus, acquired immunodeficiency syndrome, acquired immunodeficiency syndrome-related complex, or Kaposi's sarcoma, and in normal individuals American Journal of Medicine 87(4): 405-407
Frantz, J.M.; Murenzi, A. 2013: The physical activity levels among people living with human immunodeficiency virus/acquired immunodeficiency syndrome receiving high active antiretroviral therapy in Rwanda Sahara J: Journal of Social Aspects of Hiv/Aids Research Alliance 10(3-4): 113-118
Akinboro, A.O.; Onayemi, O.; Mejiuni, A.D. 2014: Frequency, pattern, and extent of skin diseases in relation to CD4+ cell count among adults with human immunodeficiency virus infection or acquired immunodeficiency syndrome in Osogbo, southwestern Nigeria International Journal of Dermatology 53(4): 416-424
De-Araujo, A.C. 1987: Cell-mediated immunity in the acquired immunodeficiency syndrome Brazilian Journal of Medical and Biological Research 20(5): 579-582
Kossaifi, T.; Dupon, M.; Le Bail, B.; Lacut, Y.; Balabaud, C.; Bioulac-Sage, P. 1990: Perisinusoidal cell hypertrophy in a patient with acquired immunodeficiency syndrome Archives of Pathology and Laboratory Medicine 114(8): 876-879
Chechani, V.; Kamholz, S.L. 1991: Optimal therapy of cryptococcosis in patients with the acquired immunodeficiency syndrome New York State Journal of Medicine 91(7): 292-296
Levine, A.M.; Gill, P.S.; Cohen, J.; Hawkins, J.G.; Formenti, S.C.; Aguilar, S.; Meyer, P.R.; Krailo, M.; Parker, J.; Rasheed, S. 1986: Suramin antiviral therapy in the acquired immunodeficiency syndrome. Clinical, immunological, and virologic results Annals of Internal Medicine 105(1): 32-37
Saccucci, P.; Mastrone, M.; Are, P.; Pisani, G.; Provenza, C. 1996: Rapidly progressive squamous cell carcinoma of the cervix in a patient with acquired immunodeficiency syndrome: case report European Journal of Gynaecological Oncology 17(4): 306-308
DeRoux, S.J.; Adsay, N.V.; Ioachim, H.L. 1991: Disseminated pneumocystosis without pulmonary involvement during prophylactic aerosolized pentamidine therapy in a patient with the acquired immunodeficiency syndrome Archives of Pathology and Laboratory Medicine 115(11): 1137-1140
Thompson, E.W.; Nakamura, S.; Shima, T.B.; Melchiori, A.; Martin, G.R.; Salahuddin, S.Z.; Gallo, R.C.; Albini, A. 1991: Supernatants of acquired immunodeficiency syndrome-related Kaposi's sarcoma cells induce endothelial cell chemotaxis and invasiveness Cancer Research 51(10): 2670-2676
Rook, A.H.; Hooks, J.J.; Quinnan, G.V.; Lane, H.C.; Manischewitz, J.F.; Macher, A.M.; Masur, H.; Fauci, A.S.; Djeu, J.Y. 1985: Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism Journal of Immunology 134(3): 1503-1507
Venkatesh, K.K.; Biswas, J.; Kumarasamy, N. 2008: Impact of highly active antiretroviral therapy on ophthalmic manifestations in human immunodeficiency virus / acquired immune deficiency syndrome Indian Journal of Ophthalmology 56(5): 391-393
Ioachim, H.L. 1990: Biopsy diagnosis in human immunodeficiency virus infection and acquired immunodeficiency syndrome Archives of Pathology and Laboratory Medicine 114(3): 284-294
Seligmann, M.; Pinching, A.J.; Rosen, F.S.; Fahey, J.L.; Khaitov, R.M.; Klatzmann, D.; Koenig, S.; Luo, N.; Ngu, J.; Riethmüller, G. 1987: Immunology of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. An update Annals of Internal Medicine 107(2): 234-242
Strawford, A.; Hellerstein, M. 1998: The etiology of wasting in the human immunodeficiency virus and acquired immunodeficiency syndrome Seminars in Oncology 25(2 Suppl 6: 76-81
Appel, G.B.; Nicolaides, M.N. 1991: Human immunodeficiency virus/acquired immunodeficiency syndrome nephropathy in the inner city New York State Journal of Medicine 91(5): 207-210
Kalaajieh WK 2000: Epidemiology of human immunodeficiency virus and acquired immunodeficiency syndrome in Lebanon from 1984 through 1998 International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 4(4): 209-213